Administration of adjuvant chemotherapy for stage II–III colon cancer patients: An European population-based study

The advantage of adjuvant chemotherapy (ACT) for treating Stage III colon cancer patients is well established and widely accepted. However, many patients with Stage III colon cancer do not receive ACT. Moreover, there are controversies around the effectiveness of ACT for Stage II patients. We invest...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Babaei, Masoud, Balavarca, Yesilda, Jansen, Lina, Lemmens, Valery, van Erning, Felice N., van Eycken, Liesbet, Vaes, Evelien, Sjövall, Annika, Glimelius, Bengt, Ulrich, Cornelia M., Schrotz-King, Petra, Brenner, Hermann
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6002808/
https://ncbi.nlm.nih.gov/pubmed/29159866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31168
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados